# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001628280-23-012964
Filing Date
2023-04-25
Accepted
2023-04-25 16:35:55
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | xfor-20221231x10k_ars.pdf | ARS | 1330231
| Complete submission text file | 0001628280-23-012964.txt |  | 1808830

Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38295 | Film No.: 23845378
SIC: 2836 Biological Products, (No Diagnostic Substances)